![Antoine Awad](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Antoine Awad
Nessuna posizione attualmente
Patrimonio netto: 50 789 $ in data 30/06/2024
Profilo
Antoine Awad served as the Chief Executive Officer at Synlogic, Inc. from 2024.
Prior to that, he worked as the Senior Vice President of Manufacturing & Operations at Abpro Corp.
He also held the position of Head of Process Sciences & Manufacturing at Merrimack Pharmaceuticals, Inc. and was a Senior Vice President at L.E.A.F.
Pharmaceuticals LLC.
Mr. Awad completed his undergraduate degree at Boston University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
SYNLOGIC INC
0.29% | 02/04/2024 | 33 859 ( 0.29% ) | 50 789 $ | 30/06/2024 |
Precedenti posizioni note di Antoine Awad
Società | Posizione | Fine |
---|---|---|
SYNLOGIC, INC. | Amministratore Delegato | 30/05/2024 |
MERRIMACK PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
L.E.A.F. Pharmaceuticals LLC
![]() L.E.A.F. Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology L.E.A.F. Pharmaceuticals LLC engages in a pharmaceuticals company. It develops and commercializes therapies for cancer, autoimmune, and infectious diseases. The company was founded by Clet Niyikiza and is headquartered in Woburn, MA. | Corporate Officer/Principal | - |
ABPRO CORPORATION | Direttore operativo | - |
Formazione di Antoine Awad
Boston University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
SYNLOGIC, INC. | Health Technology |
Aziende private | 3 |
---|---|
Abpro Corp.
![]() Abpro Corp. BiotechnologyHealth Technology Abpro Corp. operates as a biotechnology company which develops antibody therapeutics for severe and life threatening diseases. It focusses on novel antibody constructs for immuno-oncology, ophthalmology, and autoimmunity. The company was founded by Ian Chan and Eugene Y. Chan in 2007 and is headquartered in Woburn, MA. | Health Technology |
L.E.A.F. Pharmaceuticals LLC
![]() L.E.A.F. Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology L.E.A.F. Pharmaceuticals LLC engages in a pharmaceuticals company. It develops and commercializes therapies for cancer, autoimmune, and infectious diseases. The company was founded by Clet Niyikiza and is headquartered in Woburn, MA. | Health Technology |
Merrimack Pharmaceuticals, Inc.
![]() Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Antoine Awad